Andrew Craig Miller
CIK 1777760 · President of R&D · last filed 2026-05-29
Andrew Craig Miller is a President of R&D who has filed 33 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for ANRO, was dated May 29, 2026. Across all open-market trades the lifetime net is −$44.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $88.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$88.7K
3
33
-$44.46M
Holdings By Company
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | ANRO | Grant (A) | — | $0 | EDGAR |
| 2026-03-04 | KYTX | Grant (A) | +11,006 | $0 | EDGAR |
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −23,389 | -$7.72M | EDGAR |
| 2024-02-15 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | Karuna Therapeutics, Inc. (KRTX) Delisted | Tax (F) | −1,011 | -$320.6K | EDGAR |
| 2023-04-20 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | −6,500 | -$8.65M | EDGAR |
| 2023-02-13 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | +12,550 | $0 | EDGAR |
| 2022-12-22 | Karuna Therapeutics, Inc. (KRTX) Delisted | Exer (M) | +7,100 | $20.7K | EDGAR |
| 2022-12-02 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | −14,250 | -$3.42M | EDGAR |
| 2022-11-14 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | −13,000 | -$3.38M | EDGAR |